German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering.

He added that the new site enhances Stada’s capacity "to deliver quality healthcare products throughout Europe." Part of the German-based Nidda Healthcare Group, Stada Arzneimittel AG operates ...

German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. Bain Capital ...

German drugmaker Stada Arzneimittel's private-equity owners Bain Capital and Cinven are delaying a planned initial public offering of the company until September due to recent market uncertainties ...

Stada, which sells generic drugs and consumer health products, is preparing for an IPO in Frankfurt that would be among the largest in European pharma in recent years. According to a person ...

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...